Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia

Qattan, MY, Bakker, EY, Rajendran, R, Wei-Chen Chen, D, Saha, V, Liu, J, Schwartz, J, Mutti, L, Demonacos, C and Krstic- Demonacos, M ORCID: https://orcid.org/0000-0002-3914-4488 2017, 'Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia' , PLoS ONE, 12 (6) , e0178606.

PDF - Published Version
Available under License Creative Commons Attribution 4.0.

Download (5MB) | Preview
[img] PDF - Accepted Version
Restricted to Repository staff only

Download (1MB) | Request a copy


Glucocorticoids (GCs) and topoisomerase II inhibitors are used to treat acute lymphoblastic leukaemia (ALL) as they induce death in lymphoid cells through the glucocorticoid receptor (GR) and p53 respectively. Mechanisms underlying ALL cell death and the contribution of the bone marrow microenvironment to drug response/resistance remain unclear. The role of the microenvironment and the identification of chemoresistance determinants were studied by transcriptomic analysis in ALL cells treated with Dexamethasone (Dex), and Etoposide (Etop) grown in the presence or absence of bone marrow conditioned media (CM). The necroptotic (RIPK1) and the apoptotic (caspase-8/3) markers were downregulated by CM, whereas the inhibitory effects of chemotherapy on the autophagy marker Beclin-1 (BECN1) were reduced suggesting CM exerts cytoprotective effects. GCs upregulated the RIPK1 ubiquitinating factor BIRC3 (cIAP2), in GC-sensitive (CEM-C7-14) but not in resistant (CEM-C1-15) cells. In addition, CM selectively affected GR phosphorylation in a site and cell-specific manner. GR is recruited to RIPK1, BECN1 and BIRC3 promoters in the sensitive but not in the resistant cells with phosphorylated GR forms being generally less recruited in the presence of hormone. FACS analysis and caspase-8 assays demonstrated that CM promoted a pro-survival trend. High molecular weight proteins reacting with the RIPK1 antibody were modified upon incubation with the BIRC3 inhibitor AT406 in CEM-C7-14 cells suggesting that they represent ubiquitinated forms of RIPK1. Our data suggest that there is a correlation between microenvironment-induced ALL proliferation and altered response to chemotherapy.

Item Type: Article
Schools: Schools > School of Environment and Life Sciences > Biomedical Research Centre
Journal or Publication Title: PLoS ONE
Publisher: Public Library of Science
ISSN: 1932-6203
Related URLs:
Funders: The University of Salford, GIMe
Depositing User: USIR Admin
Date Deposited: 31 May 2017 07:20
Last Modified: 15 Feb 2022 22:03
URI: https://usir.salford.ac.uk/id/eprint/42474

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)


Downloads per month over past year